Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics
Genetic Epidemiology of COPD in Costa Rica
Genetic Epidemiology of COPD in Costa Rica
Sponsor study identifier
Secondary identifiers
NIH
observational
679
1 country
1
Study Start
February 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2010
Actual (reported)Study Completion
January 2010
Actual (reported)The purpose of this study is to examine genetic factors that influence the development of chronic obstructive pulmonary disease (COPD) in Hispanics, a minority group at high risk for the disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2010
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2005
Date type not reportedThis date has not been verified as actual or estimated.
March 24, 2005
Actual (reported)March 25, 2005
Actual (reported)January 2010
Actual (reported)January 2010
Actual (reported)Genetic factors that influence the development of COPD in Hispanics.
Measured through the use of genetic samples
Families of individuals with physician-diagnosed COPD and smoking-related airflow obstruction who are younger than 71 years.
Hospital Nacional de Niños
San José, Costa Rica
Hunninghake GM, Weiss ST, Celedon JC. Asthma in Hispanics. Am J Respir Crit Care Med. 2006 Jan 15;173(2):143-63. doi: 10.1164/rccm.200508-1232SO. Epub 2005 Oct 6.
Brehm JM, Celedon JC. Chronic obstructive pulmonary disease in Hispanics. Am J Respir Crit Care Med. 2008 Mar 1;177(5):473-8. doi: 10.1164/rccm.200708-1274PP. Epub 2007 Nov 20.
Brehm JM, Hagiwara K, Tesfaigzi Y, Bruse S, Mariani TJ, Bhattacharya S, Boutaoui N, Ziniti JP, Soto-Quiros ME, Avila L, Cho MH, Himes B, Litonjua AA, Jacobson F, Bakke P, Gulsvik A, Anderson WH, Lomas DA, Forno E, Datta S, Silverman EK, Celedon JC. Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax. 2011 Dec;66(12):1085-90. doi: 10.1136/thoraxjnl-2011-200017. Epub 2011 Sep 15.
Serum
Juan C. Celedon, MD, DrPH
University of Pittsburgh
679 participants (actual enrollment reported by the registry).
First Submitted
March 24, 2005
First Posted
March 25, 2005
Study Start
February 2005
Date type not reportedThis date has not been verified as actual or estimated.
Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD
Contact the study team to confirm eligibility.
Primary Completion
January 2010
Actual (reported)Study Completion
January 2010
Actual (reported)Last Updated
December 17, 2012
Record last verified: 2012-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: